Ledger.Open graph →
SEC Form D · Amendment · filed March 18, 2022

Biopharmaceutical Research Co

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CASTROVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Stephen Kurz · New York, NYDirectorScott W. Corkery · Greenwich, CTExec · DirectorGeorge B. Hodgin · Castroville, CAExec · DirectorRobert Hillman · Del Mar, CAExec · DirectorDaniel M. Green · Greenwich, CTDirectorCharles B. Schumacher · Castroville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗